year 18, Issue 72 And S12 (Supplement 12 2019)                   J. Med. Plants 2019, 18(72 And S12): 236-246 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Golabi S, Mohammadi A, Chamkouri N. Investigation of Anti-inflammatory Effect of Aqueous Extract of Cuminum cyminum L. by Formalin Inflammatory Model in Male Rats. J. Med. Plants 2019; 18 (72) :236-246
1- Assistant Profesor Abadan School of Medical Sciences, Department of Physiology, Abadan School of Medical Sciences, Abadan, Iran ,
2- M.Sc. in Biochemistry Abadan School of Medical Sciences, Department of Biochemistry, Abadan School of Medical Sciences, Abadan, Iran
3- Assistant Profesor Abadan School of Medical Sciences, Department of Biochemistry, Abadan School of Medical Sciences, Abadan, Iran
Abstract:   (2920 Views)
Background: Inflammatory pain is caused by tissue inflammation and injury. Formalin is one of most important compounds used to induce inflammation. At the moment, the recognition and development of anti-inflammatory drugs that are naturally occurring have been very much taken into consideration. Cuminum is one of plants with anti-inflammatory potentials. Considering the importance of a more complete understanding of the mechanisms that create and advance inflammation in order to find better, more complete and less complicated ways to improve inflammation and inflammatory pain, much and sometimes intense side effects of chemical treatments, The growing importance of medicinal plants in various medical fields and importance and diverse applications of Cuminum in medical sciences.
Objective: The purpose of this study was to evaluate the anti-inflammatory effect of Cuminum aqueous extract in male rats.
Method: 36 rats were used in different groups. Aqueous extract of Cuminum fruits was prepared at doses of 200, 500, 1000 mg / kg. Inflammation induced by subcutaneous injection of formalin in animal's foot and then, inflammatory pain was evaluated. One-way ANOVA was used to analyze the data.
Results: Different doses of the extract reduced the acute and chronic inflammation. The highest reduction effect in the acute phase was related to dose of 200 mg/kg and in the chronic phase, the dose was 1000 mg/kg.
Conclusion: aqueous extract of the Cuminum plant has an acute and chronic anti-inflammatory effect, and this effect is dose-dependent.
Full-Text [PDF 1017 kb]   (1276 Downloads)    
Type of Study: Research | Subject: Pharmacology & Toxicology
Received: 2018/10/19 | Accepted: 2019/01/12 | Published: 2020/03/7

1. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR and Weinstein SM. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 2003; 60 (11): 1524 - 34. [DOI:10.1001/archneur.60.11.1524]
2. Cross SA. Pathophysiology of pain. Mayo. Clin. Proc. 1994; 69 (4): 375 - 83. [DOI:10.1016/S0025-6196(12)62225-3]
3. Watkins LR, Hutchinson MR, Ledeboer A, Wieseler-Frank J, Milligan ED and Maier SF. Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain. Behav. Immun. 2007; 21 (2): 131 - 46. [DOI:10.1016/j.bbi.2006.10.011]
4. Zhuo M, Wu G and Wu LJ. Neuronal and microglial mechanisms of neuropathic pain. Mol. Brain. 2011; 4 (31): 1 - 12. [DOI:10.1186/1756-6606-4-31]
5. Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E and Przewlocka B. Importance of glial activation in neuropathic pain. Eur. J. Pharmacol. 2013; 716 (1 - 3): 106 - 19. [DOI:10.1016/j.ejphar.2013.01.072]
6. Brunton LL. Goodman & Gilman's the pharmacological basis of therapeutics: McGraw-Hill Medical New York; 2011.
7. Cronstein BN. Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU HJD. 2007; 65 (1): S11 - 5.
8. Nagakura Y, Okada M, Kohara A, Kiso T, Toya T, Iwai A, Wanibuchi F and Yamaguchi T. Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J. Pharm. Exp. Ther. 2003; 306 (2): 490 - 7. [DOI:10.1124/jpet.103.050781]
9. Yoon HM, Bae BH and Choi J. Ant nociception of intrathecal adenosine receptor subtype agonists in rat formalin test. Anesth. Analg. 2005; 101: 1417 - 21. [DOI:10.1213/01.ANE.0000180994.10087.6F]
10. Kumar S, Bajwa BS, Kuldeep S and Kalia AN. Anti-Inflammatory Activity of Herbal Plants: A Review. I. J. A. P. B. C. 2013; 2 (2): 272 - 81.
11. Saad B, Azaizeh H and Said O. Tradition and perspectives of Arab herbal medicine: a review. Evid. Based. Complement. Alternate. Med. 2005; 2 (4): 475- 79. [DOI:10.1093/ecam/neh133]
12. Calixto JB, Scheidt C, Otuki M and Santos AR. Biological activity of plant extracts: novel analgesic drugs. Expert. Opin. Emerg. Drugs. 2001; 6 (2): 261 - 79. [DOI:10.1517/14728214.6.2.261]
13. Aksoy S, Dizdar O, Altundag K. Weekly paclitaxel in the adjuvant treatment of breast cancer. N. Engl. J. Med. 2008; 358 (16): 1663 - 71.
14. Wang HK. Plant-derived anticancer agents currently in clinical use or in clinical trials. I. Drugs. 1998; 1 (1): 92 - 102.
15. Al-Snafi AE. The pharmacological activities of Cuminum cyminum- A review. I. O. S. R. P. H. R. 2016; 6 (2): 46 -6 5.
16. Singh RP, Gangadharappa HV and Mruthunjaya K. Cuminum cyminum- A Popular Spice: An Updated Review. Phcog. J. 2017; 9 (3): 292 - 301. [DOI:10.5530/pj.2017.3.51]
17. Hanif C, Ayesha T, Adila S, Saeed M, Tanveer A and Ashfaq M. Physico-chemical investigation and antimicrobial activity of essential oil of Cuminum cyminum L. World. Appl. Sci. J. 2012; 19 (3): 330 - 3.
18. Taherian AA, Etemadi H and Sadeghi H. Assessment of Aqueous Extract of Seed of Cuminum cyminum L. on Neurogenic and Inflammatory Pain in Mice. JMP. 2007; 4 (24): 44 - 50.
19. Golabi S, Hasanpour Ezati M, Azhdari H, Rohampour K, Rajabian T and Ekhteraei Tousi S. Anti-nociceptive activity of regenerated Drosera Spatulata aqueous extract by rat formalin test. JMP. 2010; 9 (33): 35 - 40.
20. Naik VR, Agshikar NV and Abraham GJ. Analgesic and anti-inflammatory activity in alcoholic extracts of Cucumis trigonus Roxburghii. A preliminary communication. Pharmacol. 1980; 20: 52 - 60. [DOI:10.1159/000137345]
21. Samsam Shariat H. Qualitative and Quantitative evaluation of the active constituents and control methods for medicinal Plants. 1st. Esfahan: Mani Publication. 1992, pp: 10 - 21 [Persian].
22. Rogerio AP, Fontanari C, Melo MC, Ambrosio SR, de Souza GE, Pereira PS, França SC, da Costa FB, Albuquerque DA and Faccioli LH. Anti-inflammatory, analgesic and anti-oedematous effects of lafoensia pacari extract and ellagic acid. J. Pharm. Pharmacol. 2006; 58: 1265 - 73. [DOI:10.1211/jpp.58.9.0014]
23. Naik VR, Agshikar NV and Abraham GJ. Analgesic and anti-inflammatory activity in alcoholic extracts of Cucumis trigonus Roxburghii. A preliminary communication. Pharmacol. 1980; 20: 52 - 60. [DOI:10.1159/000137345]
24. Fernández-Carvajal A, Fernández-Ballester G, Devesa I, González-Ros JM and Ferrer-Montiel A. New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view. The P.J. 2012; 5 (1): 16 - 48. [DOI:10.3390/ph5010016]
25. Feghali CA and Wright TM. Cytokines in acute and chronic inflammation. Front. Biosci. 1997; 2: 12 - 26. [DOI:10.2741/A171]
26. Turner NA, Mughal RS, Warburton P, O'Regan DJ, Ball SG and Porter KE. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. Cardiovasc. Res. 2007; 76 (1): 81- 90. [DOI:10.1016/j.cardiores.2007.06.003]
27. Apostolaki M, Armaka M, Victoratos P and Kollias G. Cellular mechanisms of TNF function in models of inflammation and autoimmunity. Curr. Dir. Autoimmun. 2010; 11: 1 - 26. [DOI:10.1159/000289195]
28. Bhatnagar S. Hyperalgesia: molecular mechanism and clinical implications. Indian. J. Pediatr. 2005; 72 (5): 414 - 24. [DOI:10.1007/BF02731738]
29. Ahmed M, Sadhu SK, Datta BK, Kundu JK, Bachar SC. Preliminary studies on the anti-inflammatory, analgesic and diuretic activity of stagninol, a sesquiterpene isolated from Persicaria stagnina. Die. Pharmazie. 1997; 52 (6): 472 - 5.
30. Al-Snafi AE. Chemical constituents and pharmacological importance of Agropyron repens - A review. R. J. P T. 2015; 1 (2): 37 - 41.
31. Taherian AA, Etemadi H, Sadeghi H. Assessment of aqueous extract of seed of Cuminum cyminum L. on neurogenic and inflammatory pain in mice. J. Med. Plant. Res. 2007; 4 (24): 44 - 50.
32. Luo ZD and Cizkova D. The role of nitric oxide in nociception. Curr. Rev. Pain. 2000; 4 (6): 459 - 66. [DOI:10.1007/s11916-000-0070-y]
33. Esplugues JV. NO as a signalling molecule in the nervous system. Br. J. Pharmacol. 2002; 135: 1079 - 95. [DOI:10.1038/sj.bjp.0704569]
34. Cury Y, Picolo G, Gutierrez VP and Ferreira SH. Pain and analgesia: the dual effect of nitric oxide in the nociceptive system. Nitric. Oxide. 2011; 25 (3): 243 - 54. [DOI:10.1016/j.niox.2011.06.004]
35. Cook NC, Samman S. Flavonoids- chemistry, metabolism, Cardioprotective effects, and dietary sources. J. Nutr. Biochem. 1996; 7 (2): 66 - 76. [DOI:10.1016/0955-2863(95)00168-9]
36. Packer L and Midori H. Antioxidant food supplements in human health. 1 ed. San Diego: Academic press; 1999, pp: 55 - 7.
37. Giulia DI, Carloa NM, Angelo AI, Capasso F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci. 1999; 65 (4): 337 - 53. [DOI:10.1016/S0024-3205(99)00120-4]
38. Ferrándiz ML and Alcaraz MJ. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Inflamm. Res. 2005; 32: 283 - 8. [DOI:10.1007/BF01980887]
39. Paper DH, Karall E, Kremser M and Krenn L. Comparison of the anti-inflammatory effects of Drosera rotundifolia and Drosera madagascariensis in the HET - CAM assay. Phytother. Res. 2005; 19: 323 - 6. [DOI:10.1002/ptr.1666]
40. Laughton MJ, Evans PJ, Moroney MA, Hoult JR and Halliwell BI. Inhibition of mammalian 5 - lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem. Pharmacol. 1991; 42 (9): 1673 - 81. [DOI:10.1016/0006-2952(91)90501-U]
41. Yeon sook CHI, Hyun L, Haeil P, Pyo kim H. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem. Pharmacol. 2003; 66 (7): 1271 - 8. [DOI:10.1016/S0006-2952(03)00463-5]
42. Ahmadiani A, Fereidoni M, Semnanian S, Kamalinejad M and Saremi S. Antinociceptive and anti-inflammatory effects of Sambucus ebulus rhizome extract in rat. J. Ethnopharmacol. 1998; 61 (3): 229 - 35. [DOI:10.1016/S0378-8741(98)00043-9]
43. Fernández‎ PS, Wasowski C, Loscalzo ML, Granger ER, Johnston ARG, Paladini CA and Marder M. Central nervous system depressant action of flavonoid glycosides. Eur. J. Pharmacol. 2006; 539: 168 - 76. [DOI:10.1016/j.ejphar.2006.04.004]
44. Williams JR, Spencer EPJ, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free. Radic. Biol. Med. 2004; 36 (7): 838 - 49. [DOI:10.1016/j.freeradbiomed.2004.01.001]
45. Belinda JH, Chebib M, Hanrahan RJ and Johnston RAG. Flumazenil-independent positive modulation of γ-aminobutyric acid action by 6 - methylflavone at human recombinant α1β2γ2L and α1β2GABAA receptors. Eur. J. Pharmacol. 2004; 491 (1): 1 - 8. [DOI:10.1016/j.ejphar.2004.03.014]
46. Medina JH, Viola H, Wolfman C, Marder M, Wasowski C, Calvo D and Paladini AC. Flavonoids: a new family of benzodiazepine receptor ligands. Neurochem. Res. 2004; 22 (4): 419 - 25. [DOI:10.1023/A:1027303609517]
47. Anne B. Young, Dorothy Chu. Distribution of GABAA and GABAB receptors in mammalian brain: Potential targets for drug development. Drug. Dev. Res. 1990; 21 (3): 161 - 7. [DOI:10.1002/ddr.430210303]
48. Fields HL and Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R. ed. Textbook of Pain. 4th ed. London: Churchill Livingstone. 1999, pp: 234 - 8.
49. Foley MC, Stantona JJ, Pricea ME, Cunningham TJ, Hassera ME and Heescha MC. GABAA 1 and 2 receptor subunit expression in rostral ventrolateral medulla in nonpregnant and pregnant rats. Brain. Res. 2003; 975 (1 - 2): 196 - 206. [DOI:10.1016/S0006-8993(03)02635-0]
50. Svenningsen BA, Madsen DK, Liljefors T, Stafford IG, Staden VJ and Jäger KA. Biflavones from Rhus species with affinity for the GABAA/benzodiazepine receptor. J. Ethnopharmacol. 2006; 103 (2): 276 - 80. [DOI:10.1016/j.jep.2005.08.012]
51. Wasowski C, Marder M, Viola H, Medina JH and Paladini AC. Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABA(A) receptors, from Valeriana wallichii. Planta. Med. 2002; 68 (10): 934 - 6. [DOI:10.1055/s-2002-34936]
52. Mahmoudi M and Zarrindast MR. Effect of intracerebroventricular injection of GABA receptor agents on morphine-induced antinociception in the formalin test. J. Psychopharmacol. 2002; 16 (1): 85 - 91. [DOI:10.1177/026988110201600108]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Medicinal Plants

Designed & Developed by : Yektaweb